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Abstract Human alcohol dehydrogenases of class I and class II 
but not class III catalyse NAD+-dependent aldehyde oxidation in 
addition to the NADH-dependent aldehyde reduction. The two 
reactions are coupled, i.e. the enzymes display dismutase activity. 
Dismutase activity of recombinantly expressed human class I 
isozymes [~1[~1 and T2T2, class II and class III alcohol 
dehydrogenases was assayed with butanal as snbstrate by gas 
chromatographic-mass pectrometric quantitations of butanol 
and butyric acid. The class I Y2Y2 isozyme showed a pronounced 
dismutase activity with a high kcat, 1300 min -1, and a moderate 
Km, 1.2 mM. The class I ~1111 isozyme and the class II alcohol 
dehydrogenase showed moderate catalytic efficiencies for 
dismutase activity with lower kcat values, 60-75 min -1. 4- 
Methylpyrazole, a potent class I ADH inhibitor, inhibited the 
class I dismutation completely, but cyanamide, an inhibitor of 
mitochondrial aldehyde dehydrogenase, did not affect the 
dismutation. The dismutase reaction might be important for 
metabolism of aldehydes during inhibition or lack of mitochon- 
drial aldehyde dehydrogenase activity. 
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1. Introduction 
Mammal ian  alcohol dehydrogenase (ADH)  represents a 
system of related enzymes, of which presently six classes are 
distinguished [1], capable of reducing a wide array of alde- 
hydes [2~],  and is, together with aldehyde dehydrogenase, 
aldehyde reductase and glutathione S-transferase, one of the 
major  aldehyde-metabolis ing enzymes [4]. The major organ 
for aldehyde detoxification in humans is the liver where three 
main classes of ADH have been characterised, classes I - I I I  
[5], and class I is further divided into isozymes derived from 
the presence of three subunit types (c~, [3, y) [6]. 
Horse liver ADH of class I has been reported to exhibit an 
addit ional activity, oxidation of aldehydes [7-9]. Reevaluation 
of this reaction has shown remarkably fast kinetics for the 
aliphatic aldehydes tudied: acetaldehyde, butanal  and octa- 
nal [10,11]. Simultaneous oxidation and reduction of alde- 
hydes occur when horse liver ADH is incubated with aldehyde 
and NAD +. This results in an equimolar formation of the two 
products, alcohol and carboxylic acid (Fig. 1), and no net 
reduction of the coenzyme can be observed. In competit ion 
assays, the oxidation of aldehydes was as fast as the oxidation 
of the corresponding alcohols indicating a possible physio- 
logical role for ADH-catalysed aldehyde oxidation [11]. An 
important  question is whether all ADHs  possess this 
activity. Drosophila ADH,  which is a form distinct from horse 
liver ADH (medium-chain dehydrogenases), displays aldehyde 
*Corresponding author. Fax: (46) (8) 338 453. 
dehydrogenase properties [12], while the yeast ADH has been 
reported to lack this activity [13]. 
In this study, we have investigated the dismutase activity of 
human ADH (classes I - I I I )  with the use of recombinant en- 
zymes and butanal  as substrate. For  this purpose, a method 
based on gas chromatographic-mass spectrometric analysis 
was developed for determination of product formation. 
2. Materials and methods 
2.1. Construction of expression plasmids for class I "/2 and class H 
ADH 
cDNAs coding for class I Y2 [14] and class II [15] were amplified by 
PCR using Pfu polymerase (Stratagene) under conditions recom- 
mended by the manufacturer. The cDNA coding for class I Yz was 
cloned into the unique NdeI and BamHI restriction sites of the ex- 
pression vector pET12b (Novagen), while class II cDNA was cloned 
into the NcoI and BamHI sites of pET3d, in both cases yielding 
constructs that gave no additional amino acid residues in the trans- 
lated protein. The two plasmid constructs pET127 and pET3n were 
isolated and purified with the Qiagen ion-exchange method (Diagen). 
Both plasmids were verified by dideoxy sequence analysis [16]. 
2.2. ADH expression and isolation 
Class I [31~1 and class III ADH were expressed and isolated as 
described [17,18] using expression plasmids based on the vector 
pKK223-3 (Pharmacia). The class I 72Y2 and class II ADH were ex- 
pressed in 0.5 litre cultures of E. coli strain BL21 (DE3) after induc- 
tion with a burst of 0.5 mM isopropyl-thio-13-D-galactosidase at an
ODs95 ~ 1.0 and were harvested 8-14 h later. The isolation protocol 
for class I 1~1131 was used also for class I "¢272. For isolation of class II 
ADH the cells were disrupted in 1 mM dithiothreitol, 1 mM benza- 
midine, 10 mM sodium phosphate, pH 7.5. Cells were lysed by soni- 
cation before centrifugation for 40 min at 48 000 × g. The supernatant, 
approximately 10 ml, was applied to a DEAE column (DE-52, What- 
man; 150 ml). The void volume, containing class II ADH, was ap- 
plied to a 5 ml HiTrap Blue column (Pharmacia) and eluted with 300 
mM NaCI in 10 mM sodium phosphate, pH 7.5. The fraction with 
ADH activity was further purified by exclusion chromatography on a 
25 ml Superose 12 column (Pharmacia) equilibrated with 100 mM 
NaC1, 50 mM sodium phosphate, pH 7.5. Proteins were concentrated 
(Microsep 30K cut off, Filtron) and analysed by SDS/polyacrylamide 
gel electrophoresis. Protein concentrations were determined with the 
Bio-Rad assay according to the method of Bradford [19] and comple- 
mented with amino acid analysis on a Pharmacia LKB AlphaPlus 
analyser. 
2.3. Enzyme assays 
The specific activities (units per mg protein, where one unit is de- 
fined as 1 l.tmol of NADH formed/min) of the recombinant class I 
isozymes and the class II enzyme were determined in 0.1 M glycine, 
pH 10.0 at 25°C with 33 mM ethanol and 2.4 mM NAD ÷ (Sigma). 
Class III was assayed in 0.1 M sodium pyrophosphate, pH 8.0, with 
1 mM each of glutathione (Sigma) and formaldehyde (Ladd Re- 
search). The reactions were monitored spectrophotometrically on a 
Pharmacia LKB Biochrom 4060 spectrophotometer by following the 
production of NADH (Sigma) as an increased absorbance at 340 nm. 
The production of NADH was calculated using a molar absorptivity 
of 6220 M -1 cm 1. Dismutase assays were performed at 37°C in 0.1 
M sodium phosphate, pH 7.5, 10.8 mM NAD + and with varied con- 
centrations of butanal. Butanal (Aldrich) was distilled and stored 
under nitrogen at 4°C before use. Reactions were started by addition 
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of butanal and stopped by the addition of half a volume of 12 M HCI 
to quench the enzymatic activity. Prior to addition, butanal was in- 
cubated in water for 10 min. Inhibition of the dismutation of butanal 
(5.5 mM) was tested for class I and class I| ADH with the compounds 
4-methylpyrazole (0.5-10 mM; Sigma) and cyanamide (2 mM; Amer- 
ican Cyanamide). 
2.4. Gas chromatography~mass spectrometry 
Products were extracted from the reaction mixture with 150 gl 
diethylether and the ether phase was dried with anhydrous CaSO4. 
Product concentrations were measured using a Hewlett Packard 
5890A gas chromatograph on-line with a Hewlett Packard 5972 series 
mass selective detector. An aliquot (approximately 1 gl) was injected 
on-column on a Carbowax 20M column (25 m, 0.32 mm i.d., Quadrex 
Corporation) coated with a 1 lam crosslinked film. Helium was used as 
carrier gas and the column temperature was 80°C for 4 min and was 
raised to 230°C at 20°C/min. The internal standard, 2,6-di-tert-butyl- 
4-methylphenol, present as stabiliser in the ether, and the two prod- 
ucts, butanol and butyric acid, were identified by their mass spectra s 
three dominating peaks in the chromatogram. The m/z peaks at 205, 
56 and 60, respectively, were chosen for quantitations on the basis of 
intensity and lack of interference from contaminants. The quantita- 
tions were carried out by single ion mode, and solutions with known 
concentrations of butanol and butyric acid in 0.1 M sodium phos- 
phate (pH 7.5) with 10.8 mM NAD + were used for calibration. The 
peak areas corresponding to butanol and butyric acid relative to that 
corresponding to the internal standard were found to be directly pro- 
portional to the concentrations. Standard curves were constructed by 
linear regression and used to determine the product concentrations in 
the reaction mixtures. 
Weighted non-linear egression analysis was used to calculate ki- 
netic parameters. Values of kca are based on a molecular mass of 80 
kDa for all enzymes. All kinetic values given are the means of at least 
two different measurements with protein from separate preparations. 
3. Results 
3.1. Expression and isolation of  ADH 
Recombinant  class I [31131, class I Y2Y2, class II and class I l l  
ADH were expressed in E. coli and yields of isolated proteins 
ranged from 1 mg/litre culture medium of the class I [31131 and 
3 mg of the class II I  (expression plasmids based on pKK223 
with tac promoter)  to 20 mg of the class I Y2Y2 and class II 
(expression plasmids based on pET3/12 with T7 lac promo- 
ter). The specific activities of all recombinant ADH agreed 
with previously published values for ADH purified from hu- 
man liver: class I [31131, 0.2 units/mg of protein; class I Y~2, 
0.8 units/mg of protein; class II, 1.1 units/mg of protein; class 
III, 3.4 units/mg of protein [2,20]. The values were determined 
with ethanol as substrate for classes I and II and with 
hydroxymethyl-glutathione as substrate for class III. 
3.2. Steady-state dismutase kinetics 
Dismutase reactions were carried out at 37°C in a phos- 
phate buffer of physiological pH (7.5) with a NAD + concen- 
trat ion assuring saturat ion of the enzyme. A phosphate buffer 
was used since it does not react with aldehydes which is the 
Table 1 
Kinetic constants for elimination of butanal by dismutation 
Human ADH kcat (min -1) Km (mM) kc~,JK,, 
(mM l min i) 
Class 1 131131 75 2.1 36 
Class I y2~/2 1300 1.2 1100 
Class II 60 13 5 
Class III no detectable dismutase activity 
Measurements were performed in 0.1 M sodium phosphate, pH 7.5, at 
37°C. 
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Aldehyde Carboxylic acid 
+ 
E + NAD ~ E-NAD E-NADH ~ E + NADH 
Alcohol Aldehyde 
Fig. I. Reaction scheme for aldehyde dismutation. 
case with commonly used amino-group-containing buffers, 
such as glycine and Tris-HC1 [12]. Reactions were started by 
the addit ion of butanal  that had been incubated for 10 min in 
water to establish the equil ibrium of free aldehyde and the 
hydrated gem-diol. Reaction rates, expressed as el imination 
of aldehyde, were determined by analysis of concentrations 
of products using gas chromatography-mass spectrometry. 
Reactions were quenched by lowering the pH below 1 and 
the reaction times were adjusted to yield 10-20% depletion 
of substrate. In the range of substrate concentrat ion used, 
0.32-22 mM, the reaction displayed Michael is-Menten ki- 
netics for class I and class II enzymes (Fig. 2). The rates of 
product ion of butyric acid and butanol  were equal within 
experimental errors, as required by the stoichiometry of the 
reaction. No detectable dismutat ion could be observed with 
the class III enzyme. Here substrate concentrat ions up to 110 
mM were used and reactions were run for 20 min with an 
enzyme concentrat ion of 0.25 mg/ml. Km values for the two 
class I isozymes are in the mil l imolar range and the kc~t values 
are 75 min -a and 1300 min -1 for the [3x[31 isozyme and the 
Y2)'2 isozyme, respectively. The Km value for class II was 13 
mM and kc~t was 60 rain -1 (Table 1). Addit ion of 0.5 mM of 
the potent class I ADH inhibitor 4-methylpyrazole to the 
reaction mixtures inhibited the class I dismutation completely. 
Class II ADH activity was less sensitive to 4-methylpyrazole 
with 50% inhibit ion at a concentrat ion of 1 mM and a total 
inhibit ion only at 10 mM. Cyanamide, a known inhibitor of 
mitochondrial  aldehyde dehydrogenase, did not affect the dis- 
mutation. 
4. Discussion 
Aldehydes in mammals  are mainly metabolised into the 
corresponding carboxylic acids by aldehyde dehydrogenase. 
The aldehydes can also be reduced to the corresponding alco- 
hols either by ADH or by aldehyde reductase. In addition, 
horse class I ADH has dismutase activity which results in 
both the corresponding alcohol and carboxylic acid from 
the aldehyde substrate [7,10,11]. The aim of the present study 
was to establish whether dismutation of aldehydes is catalysed 
also by human ADHs. These were prepared as homogeneous 
homodimers of four enzymes expressed as recombinant pro- 
teins in E. coli. Thus, the enzymes used were not contami- 
nated by aldehyde dehydrogenase or by ADH of other classes. 
A method to quantitate the products by gas chromatography-  
mass spectrometry was developed, since the dismutation can- 
not be followed by spectrophotometric determination of the 
coenzyme. 
The results obtained show that particular human ADHs 
display clear dismutase activity. Kinetic constants indicate 
that class I Y2Y2 has a high catalytic efficiency for this reaction, 
while class I 91131 and class II have more moderate catalytic 
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Fig. 2. Steady-state kinetics of human ADH. Rates of production 
of butanol (©) and butyric acid (e) are given as functions of buta- 
nal concentration for class I [31131 (A), class I "~2"Y2 (B) and class II 
(C) ADH. The reactions were catalysed in the presence of 10.8 mM 
NAD + and 0.1 M sodium phosphate, pH 7.5, at 37°C. 
efficiencies (Table 1). However, these constants may not be 
compared directly with those of aldehyde reduction, since 
kcatIKm are composed of different sets of fundamental rate 
constants [11]. The variation in efficiency of these ADHs re- 
flects the structural differences in the substrate-binding pocket 
[21]. The human class I isozymes how in many respects imi- 
lar characteristics to those of class I ADHs from horse, where 
the human W isozyme is the variant with the greatest posi- 
tional identity to the horse class I ADHs. The two isozymic 
forms of human class I ADH have been shown to differ in Km 
and kcat values for several substrates [2,3] and this is here 
shown in a 10-fold lower kcat for ]31131 compared to 7272. Class 
II ADH exhibits a dismutase activity comparable to that of 
the human [31131 isozyme. The class III ADH,  showing no 
dismutase activity, is the ADH that in many other respects 
shows different properties from the other ADH forms. This 
ADH cannot be saturated with ethanol and it is the only 
ADH with glutathione-dependent formaldehyde dehydrogen- 
ase activity [22]. Furthermore, this ADH has been shown to 
be the origin of the zinc-dependent ADH enzymes [23]. The 
results obtained in this study further strengthen that class III 
ADH differs in many functional respects, which can be ex- 
plained by the wider substrate-binding pocket [21]. 
Most toxic aldehydes are found in low concentrations in 
living cells, and appear to be metabolised by low Km enzymes 
such as mitochondrial aldehyde dehydrogenase. If ADH-cat- 
alysed oxidation has a physiological importance for some al- 
dehydes these might accumulate during ethanol metabolism, 
when there is little NAD + bound to ADH [24]. Furthermore, 
the reaction may be important for aldehyde metabolism dur- 
ing conditions where no or limited aldehyde dehydrogenase 
activity is present, e.g. after treatment with disulfiram or cya- 
namide, or in individuals lacking an active mitochondrial al- 
dehyde dehydrogenase. 
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